Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$2.31
-0.31-11.83%
Last update: Nov 2, 4:00 PM
BridgeBio Oncology Therapeutics Inc
BBOTNASDAQ
Market sentiment signals for BridgeBio Oncology (BBOT): analyst consensus, short interest, options flow and insider activity.
Analyst Consensus
Outperform
10 analysts
Options Flow (P/C)
—
Avg Consensus PT
$21
+817.7%
Highest Price Target
$29
+1155.4%
Lowest Price Target
$13
+462.8%
Short Interest
13.5%
Rising — Bearish
Insider Activity (30d)
—
Short Interest — % of Float
| Date | Firm | Analyst & Accuracy | Upside / Downside | PT Change | Action | Rating |
|---|---|---|---|---|---|---|
| Oct 21, 2026 | Morgan Stanley | Sean Laaman— | +462.8% | $18 → $13 | Maintained | Overweight |
| Oct 20, 2026 | Oppenheimer | Mazahir Alimohamed— | +592.6% | $22 → $16 | Maintained | Outperform |
